SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-024106
Filing Date
2024-02-05
Accepted
2024-02-05 16:31:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d710000dsc13ga.htm SC 13G/A 43344
  Complete submission text file 0001193125-24-024106.txt   44841
Mailing Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Subject) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92660 | Film No.: 24596182
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GRAPHITE BIO, INC. 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address
Porteus Matthew (Filed by) CIK: 0001864750 (see all company filings)

Type: SC 13G/A